News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
MSFT: Investors Cautious As Software Stocks Go Into EarningsMSFT: Investors Cautious As Software Stocks Go Into Earnings
News

MSFT: Investors Cautious As Software Stocks Go Into Earnings

October 24, 2022
Industrial stocks in good shape despite global economyIndustrial stocks in good shape despite global economy
News

Industrial stocks in good shape despite global economy

October 17, 2022
The problem for oil prices is demand destruction not excess supplyThe problem for oil prices is demand destruction not excess supply
News

The problem for oil prices is demand destruction not excess supply

October 13, 2022
Surveillance: Fed owes mea culpa, says DudleySurveillance: Fed owes mea culpa, says Dudley
News

Surveillance: Fed owes mea culpa, says Dudley

October 10, 2022
Memory OEMs positioned to be winners in the long term, says Mizuho’s Vijay RakeshMemory OEMs positioned to be winners in the long term, says Mizuho’s Vijay Rakesh
News

Memory OEMs positioned to be winners in the long term, says Mizuho’s Vijay Rakesh

October 10, 2022
Toast is a safe bet for growth, says Mizuho’s Dan DolevToast is a safe bet for growth, says Mizuho’s Dan Dolev
News

Toast is a safe bet for growth, says Mizuho’s Dan Dolev

October 10, 2022
Most powerful women to watch: No. 2, Mizuho Americas' Michal KatzMost powerful women to watch: No. 2, Mizuho Americas' Michal Katz
News

Most powerful women to watch: No. 2, Mizuho Americas' Michal Katz

October 5, 2022
Mizuho hires Joseph O’Doherty as head of residential mortgage financeMizuho hires Joseph O’Doherty as head of residential mortgage finance
Press Release

Mizuho hires Joseph O’Doherty as head of residential mortgage finance

October 4, 2022
Buy ratings on Merck (MRK) & Tcr2 Therapeutics (TCRR)Buy ratings on Merck (MRK) & Tcr2 Therapeutics (TCRR)
News

Buy ratings on Merck (MRK) & Tcr2 Therapeutics (TCRR)

October 3, 2022
back-to-top-blue